CV2 LIPID LEVELSAND NCEPATP-III LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS NEWLY-INITIATED ON ROSUVASTATIN ORATORVASTATIN
MF Bullano, SA Kamat, SA Williams, DA Wertz, MJ Cziraky, VJ WilleyVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)62602-2
File:
PDF, 68 KB
english, 2005